Utility of the SEER-Medicare Data to Identify Chemotherapy Use
- 1 August 2002
- journal article
- Published by Wolters Kluwer Health in Medical Care
- Vol. 40 (Supplement)
- https://doi.org/10.1097/00005650-200208001-00008
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon CancerJNCI Journal of the National Cancer Institute, 2001
- Patterns of Use of Chemotherapy for Breast Cancer in Older Women: Findings From Medicare Claims DataJournal of Clinical Oncology, 2001
- Who Gets Chemotherapy for Metastatic Lung Cancer?Chest, 2000
- Time Trends in Systemic Adjuvant Treatment for Node-Negative Breast CancerJournal of Clinical Oncology, 1999
- The quality of care for treatment of early stage breast carcinomaCancer, 1998
- The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancerBritish Journal of Cancer, 1997
- Response to the National Cancer Institute alert: The effect of practice guidelines on two hospitals in the same medical communityCancer, 1993
- Attitudes and practices regarding adjuvant chemotherapy in node-negative breast cancerJournal of Cancer Education, 1990
- Do Practice Guidelines Guide Practice?New England Journal of Medicine, 1989